MBAX 6332 Week 3 Policy Evidence Review Example

Health Policy and Systems Thinking Walden University Free custom sample in 24 to 48h

This MBAX 6332 Week 3 evidence review example asks who counts hospital-acquired conditions, how and what each count misses, before any figure enters the argument about Medicare's penalty program. Walden MBAX 6332 asks students to examine sources before using their numbers, so the review compares four publishers in one table: the program's own data, the CDC's National Healthcare Safety Network, national chart-review estimates and peer-reviewed studies, each with its population, method, lag and blind spot. Sankaran and colleagues' regression discontinuity study and Sheetz and colleagues' Michigan registry supply the evidence on effects. A lag column records that program data trail care by more than a year. Three questions are left open as contested: whether care improved, whether the measure rewards testing less and how much coding explains. Bardach and Patashnik and Haut and Pronovost support a review prepared in a Master of Business Administration (MBA) health policy course.

CourseMBAX 6332 Health Policy and Systems Thinking
WeekWeek 3
Paper typeEvidence review
LengthAbout 860 words, 6 pages
FormatAPA 7 student paper
SchoolWalden University
ProgramMaster of Business Administration (MBA)
UpdatedOctober 2026

Free sample paper for MBAX 6332 Week 3

1

Who Counts Hospital-Acquired Conditions, How and What Each Count Misses: An Evidence Review of Four Sources Before Any Figure Enters the Argument About Medicare's Penalty Program

Student Name

Walden University

MBAX 6332: Health Policy and Systems Thinking

Instructor Name

Month Day, Year

What this page is doingThe title states the review's three questions and its rule that sources are examined before their figures are used.
2

Who Counts Hospital-Acquired Conditions, How and What Each Count Misses: An Evidence Review of Four Sources Before Any Figure Enters the Argument About Medicare's Penalty Program

Purpose

Arguments about the Hospital-Acquired Condition Reduction Program often begin with a number: infection rates have fallen, penalized hospitals did not improve, safety-net hospitals are penalized more. Each number comes from a source that counts something particular, in a particular way, with particular gaps. This review asks who publishes the evidence on hospital-acquired conditions, how each source counts and what each leaves out, before the course uses any figure in its argument. It is written from the perspective of a quality analyst at a composite regional hospital who prepares the data some of these sources use. Bardach and Patashnik (2020) advise policy analysts to assemble evidence by first understanding how it was produced, since a figure's meaning depends on its method.

What this page is doingThe introduction sets the rule that evidence is described before it is weighed.
3

Four Publishers, One Table

Table 1

Sources of Evidence on Hospital-Acquired Conditions

PublisherPopulationWhat is countedMethodLagMain blind spot |
CMS program dataAcute care hospitals paid under Medicare's inpatient systemEach hospital's score on the program's measures and whether it was penalizedClaims-based safety indicators plus infection data reported to CDCPerformance periods end more than a year before the payment yearHospitals outside the program; conditions not among its measures |
CDC National Healthcare Safety NetworkHospitals reporting to the network, nearly all acute care hospitalsSpecific infections meeting surveillance definitionsStandardized infection ratios comparing observed with predicted infectionsAbout one year for national reportsInfections not sought or not cultured; non-targeted infections |
AHRQ national estimatesNational samples of hospital recordsA broader set of adverse events, including falls and drug eventsChart review of sampled recordsSeveral yearsHospital-level performance |
Peer-reviewed studiesVaries by studyEffects of the program, such as changes after penaltiesClaims, registries and statistical designsTwo to five years from data to publicationGeneralizing beyond the study's data |

Compiled for this review; descriptions summarize each source's published methods.

How Each Source Counts

The program's own data are the most directly relevant, since they decide which hospitals are penalized, but they show only what the program measures. A hospital with few catheter infections but many falls would look safe. The claims-based safety indicators depend on how conditions are coded, including whether a condition is flagged as present on admission, so coding practice affects scores.

The CDC network's infection data use standardized definitions applied by trained infection preventionists, which makes them more clinically precise than claims. But surveillance finds only infections that are looked for: a urinary infection never cultured is never counted. The network adjusts for some hospital and patient characteristics through its standardized infection ratio, but not for how often a hospital tests.

National estimates based on chart review cover more kinds of harm and are less dependent on coding, but they cannot rank individual hospitals and arrive years after the care they describe.

Peer-reviewed studies supply the evidence on whether the program works. Sankaran et al. (2019), using a regression discontinuity design on Medicare claims from more than 3,000 hospitals, found no significant shift in hospital-acquired conditions, readmissions or mortality after a first-year penalty. Sheetz et al. (2019), using a Michigan surgical registry, found that targeted conditions declined after the program began, but nontargeted conditions declined more, suggesting the program added little beyond existing trends.

What this page is doingEach source's method is described in terms of what it can and cannot show.
4

Lag as a Column

Every source trails the care it describes. The program's payment year relies on performance periods that ended more than a year earlier, so a hospital penalized this year is being judged on care delivered two or more years ago. Studies take longer still. No claim in this course should treat a published figure as a description of current performance without stating the period it covers.

Three Contested Questions

Three questions about the evidence remain contested and are described here as debated rather than settled.

First, has care improved? National infection measures have declined over the past decade, but the program began alongside other efforts, including public reporting and national campaigns, so attributing improvement to the penalty is difficult, and the studies above suggest it added little.

Second, does the measure reward looking less hard? Haut and Pronovost (2011) argued that surveillance bias can make hospitals that test more appear worse. The finding that major teaching hospitals, which tend to test and image more, were penalized more often (Rajaram et al., 2015) is consistent with this concern but does not prove it.

Third, how much do coding changes explain? Because the safety indicators come from claims, changes in documentation and present-on-admission coding can move scores without any change in patient harm. No source in the table measures this directly.

What this page is doingThe review lists the disputed questions as open, not decided, so later weeks can weigh them.
5

Implication

The course's later argument should rely on the program's data for who is penalized, on the CDC network for infection trends, on peer-reviewed studies for effects and on none of them for current performance. Each figure used should carry its source and period. Where two sources disagree, as program scores and chart-review estimates sometimes do, the disagreement itself should be reported, since it usually reflects a difference in what was counted rather than an error in either.

References

Bardach, E., & Patashnik, E. M. (2020). A practical guide for policy analysis: The eightfold path to more effective problem solving (6th ed.). CQ Press.

Haut, E. R., & Pronovost, P. J. (2011). Surveillance bias in outcomes reporting. JAMA, 305(23), 2462-2463. https://doi.org/10.1001/jama.2011.822

Rajaram, R., Chung, J. W., Kinnier, C. V., Barnard, C., Mohanty, S., Pavey, E. S., McHugh, M. C., & Bilimoria, K. Y. (2015). Hospital characteristics associated with penalties in the Centers for Medicare & Medicaid Services Hospital-Acquired Condition Reduction Program. JAMA, 314(4), 375-383. https://doi.org/10.1001/jama.2015.8609

Sankaran, R., Sukul, D., Nuliyalu, U., Gulseren, B., Engler, T. A., Arntson, E., Zlotnick, H., Dimick, J. B., & Ryan, A. M. (2019). Changes in hospital safety following penalties in the US Hospital Acquired Condition Reduction Program: Retrospective cohort study. BMJ, 366, l4109. https://doi.org/10.1136/bmj.l4109

Sheetz, K. H., Dimick, J. B., Englesbe, M. J., & Ryan, A. M. (2019). Hospital-acquired condition reduction program is not associated with additional patient safety improvement. Health Affairs, 38(11), 1858-1865. https://doi.org/10.1377/hlthaff.2018.05504

The Walden MBAX 6332 Week 3 instructions

Week 3 asks you to review the evidence on your policy by examining its sources. Identify the main publishers of data and research, and compare them on the same dimensions: the population covered, what is counted, how, how long the data lag and what each source cannot see. Describe each method in terms of what it can and cannot show. Present the comparison in a table. Then identify the questions on which the evidence is contested, and describe them as debated rather than settled. Close with guidance on which source should be used for which kind of claim later in the course. Expect three to four pages built around a single table.

How this MBAX 6332 Week 3 example is built

A purpose section states the review's rule and cites Bardach and Patashnik. A table compares the program's data, the CDC network, national chart-review estimates and peer-reviewed studies on six columns. A section explains each source's method and limits, including Sankaran and colleagues' finding of no significant change after penalties and Sheetz and colleagues' finding that nontargeted conditions improved more. A lag section warns against treating old data as current. Three contested questions follow, citing Haut and Pronovost and Rajaram and colleagues. A closing section assigns each source to the claims it can support. No figure from any source appears without its period and publisher. Each source's description ends with what it cannot show.

Where the marks sit in the MBAX 6332 Week 3 rubric

Evidence reviews are graded on whether the writer understands how evidence is produced. Comparing sources on identical dimensions earns credit, and the blind-spot column is weighted because it shows critical reading. Methods should be described accurately, including study designs. Recording data lag prevents later misuse and is valued. Contested questions should be described fairly, with evidence on each side, rather than resolved prematurely. Guidance on which source suits which claim shows that the review will be used. A review that lists findings without examining how they were produced, or that presents contested questions as settled, earns fewer marks. Readers should finish knowing which numbers to trust for which purpose.

Common MBAX 6332 Week 3 mistakes, and how to avoid them

List every source of numbers you have seen on your policy, then group them by who publishes them. For each, find out how it counts: claims, surveillance, chart review or a study design. Ask what it would miss, such as conditions never tested for or hospitals outside the program. Note how old its data are. Then list the questions people argue about and the evidence on each side. Keep each description short and neutral. Many reviews jump straight to the findings that support the writer's view. If you need help finding how a dataset was built, send us its name and we can point you to its documentation. Note the years each source covers before quoting it.

Get a MBAX 6332 Week 3 example written to your instructions

Pass along the Week 3 prompt and rubric with the policy and population your brief will address. A custom evidence review arrives within 24-48h, the first free, comparing the agencies and datasets that could supply your figures. No number appears without its publisher, and contested questions are left contested rather than settled in anyone's favor.

More MBAX 6332 papers and MBA samples

MBAX 6332 Week 3 questions, answered

Where can I find a free MBAX 6332 Week 3 sample paper?

The evidence review and its four-source comparison table are posted below, free.

Which sources does the MBAX 6332 Week 3 review compare?

The program's data, the CDC's surveillance network, national chart-review estimates and peer-reviewed studies.

Why include a lag column?

Program data trail the care they describe by more than a year, so no figure should be treated as current.

What does the evidence say about penalties?

A large study found no significant change in conditions, readmissions or deaths after a penalty.

Which questions remain contested?

Whether care improved because of the program, whether the measure rewards testing less and how much coding explains.